13 results
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockersâ €
Class II
Class I agents ... Blockersâ € Class ... .â € Class III agents ... Blockers Class ... Blockers â € Class
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
: CLASS 1 - Sodium ... Channel Blockers ... duration: - CLASS ... duration - CLASS ... & AP duration CLASS
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
: CLASS 1 - Sodium ... Channel Blockers ... duration - CLASS ... duration - CLASS ... & AP duration CLASS
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Antiarrhythmics - Sodium Channel ... Blockers Subclasses ... Antiarrhythmics #Sodium #Channel ... #Blockers #ClassI ... #pharmacology #table
A priority in this project was to appropriately stratify participants into a low, medium, or high-intensity
group-based exercise class ... The classification ... for Fall Risk Assessment ... The algorithm is ... #Fall #Risk #Screening
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Beta-Blockers ... tachycardia Calcium Channel ... vera, Licorice - Causes ... potential arrhythmias Class ... pharmacology #DDI #table
American Society of Anesthesiologists (ASA) Classification
The ASA classification (Table) aims to predict perioperative mortality rates but
(Table) aims to ... Higher ASA class ... when an ASA class ... compared with an ASA class ... and when an ASA class
In order to better classify heart failure, the American College of Cardiology Foundation and the American
direction using risk ... factors as a classification ... Association functional class ... as their status changes ... #Stages #Classes
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
ASA class If ... event, follow ACC algorithm ... Change in clinical ... Stable patients ... if result will change
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Indication: Reduce risk ... exacerbations Drug Class ... Dosing: 250 mcg tablet ... have been a few changes ... to reduce the risk